Cargando…

Propofol-Remifentanil Combination for Management of Electroconvulsive Therapy in a Patient with Neuroleptic Malignant Syndrome

Electroconvulsive therapy can be effective in severe or treatment resistant neuroleptic malignant syndrome patients. Anesthesia and use of muscle relaxant agents for electroconvulsive therapy in such patients may encounter anesthesiologists with specific challenges. This case report describes succes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arasteh, Modabber, Shami, Shoaleh, Nasseri, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324269/ https://www.ncbi.nlm.nih.gov/pubmed/22548079 http://dx.doi.org/10.1155/2012/585713

Ejemplares similares

Effects of Propofol and Propofol-Remifentanil Combinations on Haemodynamics, Seizure Duration and Recovery during Electroconvulsive Therapy
por: İkiz, Canan, et al.
Publicado: (2021)

Electroconvulsive Therapy for Neuroleptic Malignant Syndrome: A case report
por: Osca Oliver, A., et al.
Publicado: (2023)

Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion
por: Foguet-Boreu, Quintí, et al.
Publicado: (2018)

Electroconvulsive Therapy for Parkinson’s Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report
por: Mori, Yuhei, et al.
Publicado: (2021)

Rapid symptom control in neuroleptic malignant syndrome with electroconvulsive therapy: A case report
por: Katzell, Lauren, et al.
Publicado: (2023)

The effect of remifentanil on succinylcholine induced changes in serum potassium and creatine kinase: a prospective randomized double blind study
por: Nasseri, Karim, et al.
Publicado: (2017)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

Managing an effective treatment for neuroleptic malignant syndrome
por: Reulbach, Udo, et al.
Publicado: (2007)

Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics
por: Grover, Sandeep, et al.
Publicado: (2012)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

A comparison of propofol and thiopentone for electroconvulsive therapy
por: Kumar, Alok, et al.
Publicado: (2012)

Thiopental is better than propofol for electroconvulsive therapy
por: Nuzzi, Massimiliano, et al.
Publicado: (2017)

Comparison of remimazolam–remifentanil and propofol–remifentanil during laparoscopic cholecystectomy
por: Lee, Tae Young, et al.
Publicado: (2023)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline
por: Janati, A. Bruce, et al.
Publicado: (2012)

Risk Factors in Neuroleptic Malignant Syndrome
por: Gupta, Vinay, et al.
Publicado: (2003)

Resolution of symptoms in neuroleptic malignant syndrome
por: Pereira, Yvonne D.S., et al.
Publicado: (2010)

Olanzapine induced neuroleptic malignant syndrome
por: Patra, Bichitra Nanda, et al.
Publicado: (2013)

Olanzapine-Induced Neuroleptic Malignant Syndrome
por: Hosseini, Seyedhamze, et al.
Publicado: (2017)

Olanzapine-induced Neuroleptic Malignant Syndrome
por: Saha, Pradeep Kumar, et al.
Publicado: (2017)

Clozapine Induced Neuroleptic Malignant Syndrome
por: Jo, Yong Suk, et al.
Publicado: (2017)

Ziprasidone Associated Neuroleptic Malignant Syndrome
por: Bell, Jeffrey D., et al.
Publicado: (2021)

The influence of norepinephrine and phenylephrine on cerebral perfusion and oxygenation during propofol–remifentanil and propofol–remifentanil–dexmedetomidine anaesthesia in piglets
por: Mikkelsen, Mai Louise Grandsgaard, et al.
Publicado: (2018)

Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil
por: Prontera, Andrea, et al.
Publicado: (2017)

Pain reduction on injection of microemulsion propofol via combination of remifentanil and lidocaine
por: Han, Yong Ku, et al.
Publicado: (2010)

Neuroleptic malignant syndrome: A diagnostic challenge
por: Ambulkar, Reshma P, et al.
Publicado: (2012)

NEUROLEPTIC MALIGNANT SYNDROME - A CASE REPORT
por: De souza, Joaquim Victor, et al.
Publicado: (1986)

NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF 2 CASES
por: Deshmukh, D.K., et al.
Publicado: (1989)

THE NEUROLEPTIC MALIGNANT SYNDROME : REPORT OF THREE CASES
por: Sharma, R.C., et al.
Publicado: (1996)

A case of recurrent neuroleptic malignant syndrome
por: Ouyang, Zexiang, et al.
Publicado: (2013)

Two unusual complications of neuroleptic malignant syndrome
por: Ahmad, A., et al.
Publicado: (2013)

Neuroleptic malignant syndrome in cycloserine-induced psychosis
por: Sawant, Neena S., et al.
Publicado: (2015)

Neuroleptic Malignant Syndrome Associated with Valproate in an Adolescent
por: Yıldırım, Veli, et al.
Publicado: (2017)

A Neuroleptic Malignant Syndrome Without Rigidity
por: Özdemir, İlker, et al.
Publicado: (2018)

A Case of Neuroleptic Malignant Syndrome in Pregnancy
por: Mittal, Maanvi, et al.
Publicado: (2019)

Alcohol Withdrawal Mimicking Neuroleptic Malignant Syndrome
por: Farooq, Hafsa, et al.
Publicado: (2019)

Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
por: Fekadu, Abebaw, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_02vj9lrum5o3nugngkgrvq6iga